Verifying Post-delivery Anal Sphincter Integrity Using Perineal Ultrasound: Impact on Immediate Care (OASIS 2)

Verifying Anal Sphincter Integrity in the Delivery Room Using a Specific Perineal Ultrasound: Impact on Immediate Care and Postpartum Anal Incontinence Rates in Mothers Undergoing Vaginal Birth

The main objective of this study is to compare post partum rates of anal sphincter rupture (that is to say the rate of sutures) diagnosed in women with ≥ 2nd degree vaginal tears between two groups: (1) women who are screened just after delivery by performing a perineal ultrasound versus a similar group of women who did not receive screening. This study was not designed to evaluate ultrasound as a diagnostic test but to compare the rate of perineal surgical procedures in each arm.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The secondary objectives of this study are:

A. Compare the anal incontinence score (measured by the Wexner score, qualitative and quantitative assessment) at 3 months between the two groups.

B. To assess the safety of perineal ultrasound in the group with "ultrasound" using a visual analog scale for discomfort

C. Assess the inter and intra operator consistency of perineal ultrasound snapshot readings

D. Evaluate and compare the rate of infectious complications of perineal sutures between the two groups at 3 months.

E. Evaluate and compare the quality of life (questionnaires PFIQ, PFDI, SF36, Euroqol) between the two groups at 3 months.

Study Type

Interventional

Enrollment (Actual)

276

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • CHU de Montpellier - Hôpital Arnaud de Villeneuve
      • Nîmes Cedex 9, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau
      • Poitiers Cedex, France, 86021
        • Chu de Poitiers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • The patient must have given her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 3 months of follow-up
  • Paturient, vaginal births only
  • Presence of >= stage 2 perineal lesion
  • Patient accepts a priori the performance of a perineal ultrasound

Exclusion Criteria:

  • The patient is participating in another study (excepting BBBOX (2011-A00327-36), ElastoMAP (2013-A01148-37), ElastoDéclench, BAKRI, Papillo PMA, GrossPath, LXRs, DGPostPartum, "scalp lactates", and UpSideDown studies)
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • Delivery by C-section
  • Intact perineum after delivery (no indication for perineal surgery in light of absence of vaginal lesion)
  • Emergency situation preventing time for perineal ultrasound
  • History of anal incontinence before giving birth
  • Allergy to ultrasound gel

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: With ultrasound

Patients in this group will have perineal ultrasound for the detection of anal sphincter ruptures.

Intervention: Perineal ultrasound

Perineal ultrasound will be used after delivery to help detect anal sphincter ruptures.
NO_INTERVENTION: Without ultrasound
Patients in this group will not have perineal ultrasound for the detection of anal sphincter ruptures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Presence/absence of an anal sphincter rupture
Time Frame: Day 0
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SF36 questionnaire
Time Frame: 3 months
3 months
Wexner score for anal incontinence
Time Frame: Day 0
Day 0
Wexner score for anal incontinence
Time Frame: 3 months
3 months
Tolerance of perineal ultrasound
Time Frame: Day 0
Visual analog scale (0 to 10) used to evaluate discomfort.
Day 0
Kappa coefficient for inter-operator ultrasound reading
Time Frame: Day 0
Day 0
Kappa coefficient for intra-operator ultrasound reading
Time Frame: Day 0
Day 0
Presence/absence of suture infection
Time Frame: 3 months
3 months
PFIQ questionnaire
Time Frame: Day 0
Day 0
PFIQ questionnaire
Time Frame: 3 months
3 months
PFDI questionnaire
Time Frame: Day 0
Day 0
PFDI questionnaire
Time Frame: 3 months
3 months
SF36 questionnaire
Time Frame: Day 0
Day 0
Euroqol questionnaire
Time Frame: Day 0
Day 0
Euroqol questionnaire
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 7, 2014

Primary Completion (ACTUAL)

November 24, 2016

Study Completion (ACTUAL)

April 15, 2017

Study Registration Dates

First Submitted

July 19, 2013

First Submitted That Met QC Criteria

July 19, 2013

First Posted (ESTIMATE)

July 23, 2013

Study Record Updates

Last Update Posted (ACTUAL)

June 19, 2017

Last Update Submitted That Met QC Criteria

June 16, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • AOI/2012/VL-01
  • 2013-A00773-42 (OTHER: RBC number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delivery, Obstetric

Clinical Trials on Perineal ultrasound

Subscribe